Cargando…
Epigenetics of type 2 diabetes and diabetes-related outcomes in the Strong Heart Study
BACKGROUND: The prevalence of type 2 diabetes has dramatically increased in the past years. Increasing evidence supports that blood DNA methylation, the best studied epigenetic mark, is related to diabetes risk. Few prospective studies, however, are available. We studied the association of blood DNA...
Autores principales: | Domingo-Relloso, Arce, Gribble, Matthew O., Riffo-Campos, Angela L., Haack, Karin, Cole, Shelley A., Tellez-Plaza, Maria, Umans, Jason G., Fretts, Amanda M., Zhang, Ying, Fallin, M. Daniele, Navas-Acien, Ana, Everson, Todd M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759920/ https://www.ncbi.nlm.nih.gov/pubmed/36529747 http://dx.doi.org/10.1186/s13148-022-01392-7 |
Ejemplares similares
-
An epigenome-wide study of DNA methylation profiles and lung function among American Indians in the Strong Heart Study
por: Domingo-Relloso, Arce, et al.
Publicado: (2022) -
Epigenetic Biomarkers of Lead Exposure and Cardiovascular Disease: Prospective Evidence in the Strong Heart Study
por: Lieberman‐Cribbin, Wil, et al.
Publicado: (2022) -
Cadmium, Smoking, and Human Blood DNA Methylation Profiles in Adults from the Strong Heart Study
por: Domingo-Relloso, Arce, et al.
Publicado: (2020) -
DNA methylation and cancer incidence: lymphatic–hematopoietic versus solid cancers in the Strong Heart Study
por: Domingo-Relloso, Arce, et al.
Publicado: (2021) -
Maternal DNA methylation signatures of arsenic exposure is associated with adult offspring insulin resistance in the Strong Heart Study
por: Dye, Christian K., et al.
Publicado: (2023)